Model Number BXA073902A |
Device Problem
Obstruction of Flow (2423)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/10/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
As it is not known which device or both became occluded, the following additional device was also investigated: sn# (b)(4), udi: (b)(4).Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Event Description
|
On (b)(6) 2020 a patient underwent aortic aneurysm treatment within the (b)(6) clinical study.Two gore® viabahn® vbx balloon expandable endoprosthesis were utilized in the celiac artery.On (b)(6) 2020 celiac artery stenosis was reported.
|
|
Event Description
|
On (b)(6) 2020 a patient underwent aortic aneurysm treatment within the tambe 1701 clinical study.Two gore® viabahn® vbx balloon expandable endoprosthesis were utilized in the celiac artery.On (b)(6) 2020 celiac artery stenosis was reported.On february 17, 2021 documentation was received indicating the patient had an imaging test of unknown modality showing occlusion of the celiac trunk.However the gray-scale, pulse wave doppler and color flow duplex imaging performed on this day showed that the celiac artery was patent with normal flow velocities and doppler profile.Of note this exam could be in error, as this vessel was technically difficult to examine.
|
|
Manufacturer Narrative
|
H.6.Results code 1: 213: a review of the manufacturing records for the devices verified the lots met all pre-release specifications.
|
|
Search Alerts/Recalls
|